FLUOROQUINOLONE USE AND FLUOROQUINOLONE RESISTANCE - IS THERE AN ASSOCIATION

被引:82
作者
RICHARD, P
DELANGLE, MH
MERRIEN, D
BARILLE, S
REYNAUD, A
MINOZZI, C
RICHET, H
机构
[1] CHU NANTES,HOTEL DIEU,BACTERIOL LAB A,NANTES,FRANCE
[2] LABS SCHERING PLOUGH,LEVALLOIS PERRET,FRANCE
关键词
D O I
10.1093/clinids/19.1.54
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In an assessment of potential risk factors for nosocomial infections caused by fluoroquinolone-resistant gram-negative organisms, 68 patients who developed a nosocomial infection caused by a fluoroquinolone-resistant gram-negative bacillus were compared with 191 patients who developed a nosocomial infection caused by a fluoroquinolone-susceptible gram-negative bacillus. A history of previous infection, immunosuppression, prior receipt of fluoroquinolones, and hospitalization on the burn unit were independent risk factors. Except for immunosuppression, the same risk factors were identified when the 50 patients whose isolates were resistant to fluoroquinolones, aminoglycosides, and beta-lactam antibiotics were compared with the 95 patients whose isolates were susceptible to all of these classes of antimicrobial agents. The identification of hospitalization on the burn unit as a risk factor was attributable to an outbreak of infections caused by a resistant strain of Pseudomonas aeruginosa during the study period. The occurrence of nosocomial outbreaks and the selective pressure of fluoroquinolone use were the main exogenous risk factors involved in the emergence of resistance to fluoroquinolones.
引用
收藏
页码:54 / 59
页数:6
相关论文
共 13 条
[1]  
ARDUINO S, 1992, 32ND INT C ANT AG CH, P38
[2]  
Fung-Tomc J, 1990, ANTIMICROB NEWSLETT, V7, P17
[3]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[4]   DEVELOPMENT OF RESISTANCE TO NALIDIXIC-ACID AND THE FLUOROQUINOLONES AFTER THE INTRODUCTION OF NORFLOXACIN AND OFLOXACIN [J].
KRESKEN, M ;
WIEDEMANN, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1285-1288
[5]  
MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033
[6]   RESISTANCE OCCURRING AFTER FLUOROQUINOLONE THERAPY OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PERITONITIS [J].
MICHEAHAMZEHPOUR, M ;
AUCKENTHALER, R ;
REGAMEY, P ;
PECHERE, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (11) :1803-1808
[7]   ASSOCIATION WITH PRIOR FLUOROQUINOLONE THERAPY OF WIDESPREAD CIPROFLOXACIN RESISTANCE AMONG GRAM-NEGATIVE ISOLATES IN A VETERANS AFFAIRS MEDICAL-CENTER [J].
MUDER, RR ;
BRENNEN, C ;
GOETZ, AM ;
WAGENER, MM ;
RIHS, JD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) :256-258
[8]   GYRA SEQUENCE-ANALYSIS OF STAPHYLOCOCCUS-AUREUS AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS STRAINS SELECTED, IN-VITRO, FOR HIGH-LEVEL CIPROFLOXACIN RESISTANCE [J].
PETERSON, LR ;
WILLARD, KE ;
SINN, LM ;
FASCHING, CE ;
GERDING, DN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 17 (02) :97-101
[9]   PHENOTYPIC CHARACTERIZATION OF QUINOLONE-RESISTANT MUTANTS OF ENTEROBACTERIACEAE SELECTED FROM WILD-TYPE, GYRA-TYPE AND MULTIPLY-RESISTANT (MARA)-TYPE STRAINS [J].
PIDDOCK, LJV ;
HALL, MC ;
WALTERS, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (02) :185-198
[10]   SUPERINFECTIONS BY ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES IN IMMUNOCOMPROMISED PATIENTS [J].
SOMOLINOS, N ;
ARRANZ, R ;
DELREY, MC ;
JIMENEZ, ML .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (05) :730-731